The AGITG Publications Policy and guidelines for authorship were updated in 2019. The guidelines are outlined in full below.
- Presentation of the primary results of the main study should include group authorship where
possible with a list of specific contributions at the end.
- AGITG will be acknowledged in all publications (including conference presentations, medial releases
- As per the ICMJE guidelines (www.icmje.org), an ‘author’ is considered to be someone who has made
substantive intellectual contributions to a published study. Authorship credit should be based on:
3.1. Substantial contributions to the conception and design, or acquisition of data, or analysis and
interpretation of data
3.2. Drafting the article or revising it critically for important intellectual content
3.3. Final approval of the version to be published.
3.4. Authors should meet conditions 1, 2 and 3 above.
- Eligibility for authorship will be based on the following factors:
4.1. Substantial contribution to the trial design and protocol development,
4.2. Substantial contribution to the management and conduct of the trial,
4.3. Substantial contribution to the analysis and interpretation of the data,
4.4. Level of contribution of participants to the study.
- Study Chair or Co-Chair should be the first (potentially two) author(s) on the basis that:
– Study Chair or Co-Chair has ensured the success of the study.
– Study Chair or Co-Chair has made significant contributions to the scientific ideas on which
the study was based and to the writing of the manuscript.
– Study Chair or Co-Chair is a guarantor of the study.
5.1. In the event there are two Co-Chairs on a trial, the arrangements for authorship should be
determined in consultation with the Trial Management and the Operations Executive
committees before commencement of the study.
5.2. In the event there are Co-Chairs on a trial, every effort should be made to ensure there are
opportunities for more than one publication and that both Co-Chairs can have a first-author
5.3. A Co-Chair who is not the first author should choose whether to be second author or last author.
- Statistician should be a principal author (second, third or fourth author) on the basis that:
– The Statistician has made a significant contribution to the scientific principles of the study.
AGITG Publication Policy – Ratified 4 April 2019 Page 3 of 6
– The Statistician has been a prime contributor to the study design, determination of sample
size and scientific conduct of the study (unblinding principles, analysis principles,
interpretation of results, compliance, etc.)
– The Statistician guarantees the scientific integrity of the study.
- AGITG-CTC Group Coordinator should be considered as an author to reflect their contribution
throughout the lifecycle of the trial (development, conduct, analysis and publication) for studies
coordinated by the NHMRC CTC, if in compliance with the policy criteria.
- SAC Chair should be considered as an author to reflect their contribution throughout the lifecycle of
the trial (development, conduct, analysis and publication), if in compliance with the policy criteria.
- Subsequent authors will comprise clinicians or other scientists who have made scientific or
intellectual contributions to the study question or the study conduct and meet the journal’s
requirements for authorship, including members of the TMC.
- Acquisition of funding, collection of data, or general supervision of the research group, alone, does
not justify authorship.
- Contributors listed in Acknowledgements:
– Any person who contributes to the success of the study or the progress of the manuscript
but does not qualify for authorship should (with his/her permission) be acknowledged in the
– All participating sites and the coordinating centre will be acknowledged in the manuscript.